Article

Health-related quality of life in breast cancer: A cross-cultural survey of German, Japanese, and South Korean patients.

Institute of Medical Psychology, University Medical Center Hemburg-Eppendorf, Martinistr,52-S35, 20246, Hamburg, Germany.
Breast Cancer Research and Treatment (Impact Factor: 4.2). 11/2006; 99(3):341-50. DOI: 10.1007/s10549-006-9216-x
Source: PubMed

ABSTRACT The aim of this study was to evaluate health-related quality of life (HRQOL) in breast cancer patients across countries, and to cross-culturally examine the impact of psychosocial factors on HRQOL.
A total of 413 women with breast cancer from Germany (n = 195), Japan (n = 112), and Korea (n = 106) completed a survey assessing HRQOL and HRQOL-related factors. HRQOL was measured using the Short-Form Health Survey (SF-8). Measures of psychological distress (Hospital Anxiety and Depression Scale and Impact of Event Scale-Revised), coping (Dealing with Illness Inventory-German Revised), and social support (Illness-Specific Social Support Scale-German Revised) were included.
The effect of the factor country on physical QOL was seen to be significant, but small (P = 0.049, ES = 0.018). The scales of General Health (P = 0.023), Vitality (P = 0.004), and Role Emotional (P = 0.003) differed across countries, with the South Korean patients having lower scores compared to the German and Japanese patients. The nature of the impact of psychosocial factors on HRQOL did not differ greatly across countries except with regard to avoidance, however, the degree to which these factors influence HRQOL did differ greatly. Overall, depression, depressive coping, and problematic support showed a strong detrimental effect on the HRQOL of breast cancer patients.
Results from this study suggest that strategies which target an improvement of HRQOL in cancer patients should also consider the patients' cultural and healthcare system contexts. Interventions are needed to improve detrimental psychosocial factors.

Full-text

Available from: Anja Mehnert, Oct 13, 2014
1 Follower
 · 
146 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: (i) To assess the health-related quality of life (HRQOL) and analyse the potential contributing factors of HRQOL in elderly cancer patients in China; and (ii) to evaluate the possible correlation between the Medical Outcomes 36-Item Short Form Health Survey (SF-36) and the European Organization for Research and Treatment of Cancer, quality of life questionnaire (EORTC QLQ-C30). A total of 109 elderly patients undergoing chemotherapy with advanced cancer completed a survey assessing HRQOL, anxiety and depression. HRQOL was measured by SF-36 and EORTC QLQ-C30. Anxiety and depression, was measured by the Hospital Anxiety and Depression Scale (HADS). Scales pertaining to role functioning, including SF-36 role physical (25.92 ± 37.10) and role emotional (36.12 ± 43.50), EORTC QLQ-C30 role functioning (46.94 ± 36.86), were the worst domains of SF-36 and EORTC QLQ-C30 respectively. Financial impact (55.77 ± 36.55) and fatigue (46.18 ± 26.48) were the top two highest scores among all nine symptom-related scales of EORTC QLQ C-30. The correlation matrix of SF-36 versus EORTC QLQ-C30 showed that, in general, there was good correlation between scales pertaining to the same health domain, and low correlation was observed between scales pertaining to different domains. The findings of this study highlight role functioning, financial impact, fatigue, anxiety, and depression as areas where elderly cancer patients could most benefit from intervention. These findings also call attention to HRQOL and its related factors in elderly cancer patients. Interventions to be developed for improving HRQOL in cancer patients are highly recommended.
    European journal of oncology nursing: the official journal of European Oncology Nursing Society 04/2014; DOI:10.1016/j.ejon.2014.03.005 · 1.79 Impact Factor
  • Source
    The Obstetrician & Gynaecologist 01/2011; 13(1). DOI:10.1576/toag.13.1.22.27637
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose In the present study, we aimed to investigate the effects of chemotherapy-induced peripheral neurotoxicity (CIPN) on psychological distress and sleep quality in cancer patients. Methods A total of 706 cancer patients were interviewed for the study. In the 4th week of treatment, patient CIPN was measured using the Patient Neurotoxicity Questionnaire (PNQ). The sleep quality and psychological distress of patients were measured using the Pittsburgh Sleep Quality Index (PSQI), the Distress Thermometer (DT), and the Hospital Anxiety and Depression Scale (HADS). Multiple logistic regression was applied to determine the independent effects of CIPN on psychological distress and sleep disturbance in the patients. Results These correlation coefficients were obtained: 0.387 (p < 0.0001) between the PNQ total score and the DT score, 0.386 (p < 0.0001) between the PNQ total score and the HADS Depression score, 0.379 (p < 0.0001) between the PNQ total score and the HADS Anxiety score, and 0.399 (p < 0.0001) between the PNQ total score and the PSQI global score. The prevalence rates of distress, depression, anxiety, and poor sleep quality in the five PNQ grades were statistically significantly different (p < 0.0001). After controlling for age, sex, education level, social supports, fatigue, disease stage, and tumour site, the PNQ grades were found to be associated with depression (p < 0.0001), anxiety (p < 0.0001), and poor sleep quality (p < 0.0001). Conclusions Chemotherapy-induced peripheral neurotoxicity negatively affects psychological distress and sleep quality in cancer patients treated with chemotherapy. High PNQ grades were significantly associated with poor psychological status and sleep quality. Our results emphasize the importance of assessing peripheral neuropathies during chemotherapy and of adjusting treatment plans based on assessment results.
    08/2014; 21(4):174-80. DOI:10.3747/co.21.1984